KIBRA Antibodies

Santa Cruz Biotechnology provides a broad selection of KIBRA monoclonal antibodies for investigating cellular processes. KIBRA monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIBRA plays a critical role in regulating cellular signaling pathways and influences memory formation and synaptic plasticity. Research has demonstrated KIBRA's significance in the Hippo signaling pathway, which affects cell growth and tissue homeostasis. Studies have linked KIBRA to various diseases, making it an important focus in neurobiology and cancer research. Understanding KIBRA's functions continues to reveal new insights into cellular mechanisms and disease pathways. Ongoing research with KIBRA has uncovered its involvement in memory consolidation and neural plasticity. KIBRA's role in cell signaling networks presents opportunities for therapeutic development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of KIBRA's biological significance and potential therapeutic applications.